Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
14,560.00    20.00 (0.14%)
Bid:
15,280.00
Ask:
12,760.00
Spread: -2,520.00 (-16.492%)
Market Cap: £1.11b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

Acquisition

23 Mar 2007 09:15

Goodwin PLC23 March 2007 Goodwin PLC ("Goodwin" or the "Company") 23 March 2007 ACQUISITION OF NOREVA GmbH Goodwin, the mechanical and refractory engineering group, announces theacquisition of 75% of the share capital of Noreva GmbH ("Noreva"), amanufacturer of non return nozzle check valves located in Monchengladbach,Germany for an initial consideration of £2.8 million in cash. In the year to 31 December 2006 Noreva generated turnover of Eur 7.3 million (£5 million), profit before tax of Eur 0.42 million (£0.288 million) and has gross assets of Eur 4.3 million (£2.9 million) audited. The remaining 25% share interest, which is owned equally by the two currentManaging Directors of Noreva, Messrs R. Kurzenberg and M. Sattelberg (the"Managing Directors"), who are to continue to serve Noreva in their presentcapacity following the acquisition, is subject to put options exercisable by the Managing Directors no sooner than 5 years, and a call option exercisable byGoodwin PLC no earlier than 12 years, from the date of completion of theacquisition. The initial consideration is £2.8 million in cash, together with £0.6 millionpayable to Noreva (i.e. funds retained within the Goodwin group) for a perpetualtechnology licence. A deferred consideration of an additional £1.0 million willbe paid in two instalments, payable after three and five years after completion,respectively. The consideration in case of the exercise of the put and/or calloption will be either £1.0 million for the remaining 25 % of the Novera sharesor is to be calculated based on 10 times annual average pre-tax profit of Noreva for three years prior to the exercise of the option, or a combination of both calculation methods, depending on, inter alia, the term of service of therespective Managing Director. The Company believes that Noreva is a complementary business and anticipatessignificant value being created from the excellent synergy in the marketing andproduction capacity opportunities between Noreva and Goodwin's UK basedsubsidiaries Goodwin International Ltd and Goodwin Steel Castings Ltd (the"Goodwin Companies"). The Goodwin Companies manufacture and supply dual platenon-return check valves for the oil and gas industry worldwide, whereas Norevasupplies a complementary but more costly and faster-acting nozzle check valve to applications requiring less backflow and pressure surge. Noreva and the Goodwin Companies will continue to benefit from each others'technology and marketing resources, which are also complementary. Financing fromGoodwin will enable Noreva to extend its facility in Monchengladbach and anagreed cooperation in the area of distribution will enable each company toreduce lead times and provide a faster service to their customers and achieveincreased sales. The acquisition of Noreva will enable the Goodwin Companies and Noreva tofurther strengthen their relative market positions through the ability to offercomplete check valve solutions to their principal markets in the hydrocarbon,processing and water industries. Francis Gaffney, Director and General Manager of Goodwin International Ltd anda main board director of Goodwin PLC, will become a Managing Director of Noreva,together with the existing Managing Directors. Enquiries: John GoodwinTel: +44 1782 220000Goodwin PLC END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Aug 20194:36 pmRNSPrice Monitoring Extension
9th Aug 20192:51 pmRNSResults Update
15th Jul 20194:35 pmRNSPrice Monitoring Extension
5th Jul 20194:35 pmRNSPrice Monitoring Extension
1st Jul 20194:41 pmRNSSecond Price Monitoring Extn
1st Jul 20194:36 pmRNSPrice Monitoring Extension
26th Jun 201912:07 pmRNSSecond Price Monitoring Extn
26th Jun 201912:02 pmRNSPrice Monitoring Extension
12th Jun 20192:00 pmRNSChange of Adviser
11th Jun 20194:35 pmRNSPrice Monitoring Extension
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd May 20198:42 amRNSDirector/PDMR Shareholding
1st May 201910:03 amRNSDirectorate Change
8th Apr 20191:28 pmRNSDirector/PDMR Shareholding
8th Apr 201912:08 pmRNSSecond Price Monitoring Extn
8th Apr 201912:02 pmRNSPrice Monitoring Extension
2nd Apr 20199:27 amRNSProduct Innovation
2nd Jan 20199:15 amRNSCompany Secretary Change
18th Dec 201810:18 amRNSHalf-year Report
8th Oct 201812:22 pmRNSDirector/PDMR Shareholding
4th Oct 20187:00 amRNSResult of AGM
13th Aug 20183:25 pmRNSPosting of Annual Report and Accounts
26th Jul 20188:10 amRNSPreliminary Results
8th Mar 20184:40 pmRNSSecond Price Monitoring Extn
8th Mar 20184:35 pmRNSPrice Monitoring Extension
6th Mar 20184:35 pmRNSPrice Monitoring Extension
18th Dec 201711:00 amRNSHalf-year Report
25th Oct 20177:00 amRNSDirector/PDMR Shareholding
13th Oct 20173:32 pmRNSDirector/PDMR Shareholding
4th Oct 20173:30 pmRNSResult of AGM
13th Sep 20171:00 pmRNSQuarterly Interim Management Statements
31st Aug 201710:49 amRNSAnnual Financial Report
22nd Aug 20173:32 pmRNSPreliminary Results
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
13th Mar 20174:40 pmRNSSecond Price Monitoring Extn
13th Mar 20174:35 pmRNSPrice Monitoring Extension
10th Mar 20172:15 pmRNSInterim Management Statement
16th Dec 201612:28 pmRNSHalf-year Report
10th Oct 20164:35 pmRNSPrice Monitoring Extension
10th Oct 20161:56 pmRNSDirector/PDMR Shareholding
5th Oct 20163:06 pmRNSResult of AGM and LTIP awards
16th Sep 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20162:40 pmRNSInterim Management Statement
12th Aug 20164:52 pmRNSAnnual Financial Report
29th Jul 20167:00 amRNSPreliminary Results
13th May 20164:35 pmRNSPrice Monitoring Extension
13th May 201610:08 amRNSDirector/PDMR Shareholding
17th Mar 201610:00 amRNSInterim Management Statement
10th Mar 20163:32 pmRNSHome Member State
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.